Phathom Pharmaceuticals (PHAT) Inventory Average (2023 - 2026)
Phathom Pharmaceuticals (PHAT) reported Inventory Average of $6.0 million for Q1 2026, up 88.67% year-over-year from $3.2 million in Q1 2025, and up 31.73% quarter-over-quarter from $4.6 million in Q4 2025.
Phathom Pharmaceuticals (PHAT) Inventory Average (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 4 years of Inventory Average data on file, last reported at $6.0 million in Q1 2026.
- Inventory Average for Q1 2026 came in at $6.0 million, up 88.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (up 88.67% YoY), and the FY2025 annual result was $4.4 million, up 97.6% from the prior year.
- Inventory Average climbed to $6.0 million in Q1 2026 per PHAT's latest filing, from $4.6 million in the prior quarter.
- Over five years, Inventory Average peaked at $6.0 million in Q1 2026 and troughed at $111000.0 in Q3 2023.
- A 4-year average of $2.8 million and a median of $3.2 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2024 and 2025: Inventory Average surged 2281.98% in 2024, then soared 33.17% in 2025.
- A 4-year view of Inventory Average shows it stood at $659500.0 in 2023, then jumped by 379.08% to $3.2 million in 2024, then surged by 44.47% to $4.6 million in 2025, then surged by 31.73% to $6.0 million in 2026.
- Business Quant data shows PHAT's Inventory Average at $6.0 million in Q1 2026, $4.6 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 895.99 Mn | 712.23 Mn | 46.31 Mn | 6.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.01 Mn |
| Dec 31, 2025 | 4.56 Mn |
| Sep 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | 3.16 Mn |
| Sep 30, 2024 | 2.64 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 659,500.00 |
| Sep 30, 2023 | 111,000.00 |